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Introduction 
 
Human being has been living on the earth for extremely long history. 
What was the living environment like in the ancient period? There was 
always a shortage of food associated with difficulty of survival [1]. 
Consequently, human was always fighting hunger and fasting for a 
long time. These severe conditions have influenced much for human 
evolution of metabolic flexibility [2]. As a matter of fact, hunger and 
fasting situation for human body has brought several benefits 
concerning human metabolic changes of hyperketonemia [3]. It may 
contribute human health with the metabolic research development 
nowadays. In this article, these topics would be described.  
 
Concerning hyperketonemia, there has been various discussion of 
nutritional treatment of Low Carbohydrate Diet (LCD), weight 
reduction and Ketogenic Diet (KD). KD has been a special type of 
LCD, in which intake of carbohydrate is limited usually less than 50g 
per day. KD has been reported to promote metabolic health and 
protection against cancer and other Non-Communicable Diseases 
(NCDs) [1]. The mechanisms include decreased insulin levels, 
increasing mitochondrial substrate oxidation and specific anti-oxidative 
and anti-inflammatory effects of Ketone Bodies (KB) [4].  
 
KD has been recently discussed in focus as one of the effective 
nutritional and diet therapy. The history of KD was initiated around 
1920s for the treatment of epilepsy, autistic behavior and fasting in 
child obesity. The treatment of KD at that time was highly evaluated 
because of its satisfactory results [5]. After that, KD has been prevalent 
and applied to children with epilepsy across the world. In contrast, KD 
therapy for adult and elderly has been limited with rare experiences [6].  
 
As metabolic syndrome such as obesity and diabetes has been recently 
so prevalent worldwide, KD has been in focus expecting the efficacy 
for these diseases. In order to reduce weight in such subjects, LCD was 
formerly introduced to health and medical field by Atkins and 
Bernstein. They had spread LCD with showing significant efficacy of 
reducing weight [7,8]. After LCD was a gradually accepted and well-
known in European and North American country with successful 
results, author and colleagues have started LCD in Japan [9]. We have  
 
 
continued clinical research of LCD for various patients and educational 
activities such as workshop and books for long [10]. For practical use 
of LCD, three LCD methods have been proposed and prevalent. They 
are petite LCD, standard LCD and super LCD, which has carbohydrate 
ratio of 40%, 26%, 12%, respectively [11]. Among them, super LCD 
has been equivalent to the KD. For example, total calorie intake per 
day is 1400 kcal/day. As carbohydrate ratio is 12%, then carbohydrate 
is calculated as 168 kcal/day, which equals to the amount of 42g of 
carbohydrate intake per day [12].  
 
KD has been known to show several beneficial health and medical 
efficacy. The reason is due to elevated KB in the blood. Formerly, 
there was misunderstanding that hyperketonemia is believed to be risky 
clinical situation. In recent years, however, correct information has 
been known. They are i) elevated KB in blood is not risky matter 
except diabetic coma, ii) brain and muscle can use KB for energy 
production which is similar to glucose, iii) KB have anti-cancer effects 
proved by much evidence, iv) blood KB values show high in the axis 
of fetus, placenta, newborn and pregnant mother which suggests 
physiologically quite important roles for energy and growth by our 
research [13,14].  
 
KB seems to have crucial metabolic function on growth in human. 
What is metabolic condition on animal species like? There are 
probably two metabolic pathways, which are i) the brains of 
neurologically precocial and mature species, ii) the brains of 
neurologically no-precocial and immature species such as rat and 
human [15]. The former case has the ability for complete oxidation of 
glucose, indicating aerobic glycolysis In contrast, the latter has the 
ability of mixed metabolism for glucose and KB so as to generate 
synthetic and energetic activities [15].  
 
In the case of mammals, there is the ability of converting energy stored 
in KB into high energy phosphates. KB can transport fuel particularly 
to the brain, heart and muscles in various conditions. They include 
fasting, starvation, nutrition treatment on LCD and circumstances of 
fetus and neonatal periods [16]. From comparison of animal species 
and related biochemical data, the fetus of most animals have been 
raised and developed by the energy obtained from KB produced in the 
body [17]. 
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Concerning KB which can yield much energy, there are clinically two 
types of active KB. They are beta-hydroxybutyrate (βHB, 3-
hydroxybutyric acid, 3-OHBA) and Acetoacetic Acid (AcAc) [18,19]. 
These two can be converted to each other. The former occupies about 
60-90 % in the blood and the latter 10-40% [20,21]. From the 
functional point of view, βHB has shown the main function of KB. 
Thus KB would always support the growth and survival of the 
mammals during energy deficits by becoming energy-producing engine 
as an alternative source of ATP.  
 
There was an important data concerning the level of βHB. Healthy 
person usually shows 72-90 mg/dL of glucose and less than 0.2 
mmol/L of βHB. Fasting elevates βHB, and its level is 0.3-0.5 mmol/L 
in 24 hours, 1-2 mmol/L in 2-3 days, 3 mmol/L in 3-4 days, and 4-5 
mmol/L in 7-10 days. When obese patients continued fasting for 40 
days, they did not show acidosis and their βHB values were 6-8 
mmol/L [18,20].  
 
Authors have reported the KB values on LCD in patients with Type 2 
Diabetes Mellitus (T2DM) [21]. The intervention was super-LCD, 
which was the protocol meal with 1400kcal/day, 12% of carbohydrate 
and 42g of carbohydrate per day. KB levels were 0.16--4 mmol/L, and 
βHB levels were 0.14-3.58 mmol/L. The continuation period of LCD 
was from 4 to 28 days.  
 
Recently, there is a new concept of “Neuroketotherapeutics” [22]. It 
shows a class of bioenergetics medicine therapies which feature the 
induction of ketosis. They include classic ketogenic diet, modified 
Atkins diet, fasting, ketone esters, medium-chain triglyceride 
supplements, and so on. The mechanism would be β-
hydroxybutyrylation and lysine acetylation, and various effects would 
include reduced inflammation, attenuated oxidative stress, enhanced 
mitochondrial respiration, elevated neuronal long-term potentiation and 
altered protein post-translational modifications. Further investigation of 
neuroketotherapeutics will develop KB molecular biology and show 
new central nervous system therapeutic applications [22].  
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